Global Vice President, IcoSema
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Global Vice President, IcoSemaThis is a once in a life-time career opportunity to lead, develop and drive the global commercial launch strategy for a new asset within Diabetes, IcoSema, which is a combination of once-weekly insulin Icodec and once-weekly GLP-1 Semaglutide. Phase III clinical programmes are expected to be finalised in 2024 and the commercial team is gearing up for launch.Would you like to be part of this inspiring challenge and help us transform insulin treatment? Are you a strong commercial leader with an outstanding track record of pre-launch and in-market brand management of pharmaceutical products? Do you hold strong people leadership capabilities? Then this is your chance to join Novo Nordisk and lead the team through the commercial launch of this exciting new asset. Start your application for a life-changing career now!The position
Reporting to the Global Head of the Insulin Portfolio Unit, the Global Vice President (VP) will own the entire commercial, brand and go-to-market strategy for IcoSema globally and will lead the marketing team in preparing for the launch. The new VP will lead a cross-functional launch team to secure operational readiness of IcoSema in key affiliates.In collaboration with colleagues in the global project and marketing team, regional and affiliate offices, the new VP will:Own the strategic development of the entire brand strategy from aspiration, go-to market to brand launch package, ensuring launch readiness in top affiliates Drive positioning and portfolio strategies to secure optimal placement of Novo Nordisk’s fourth generation insulin Lead the development and co-creation of innovative commercial strategies and campaigns Lead commercial input and strategies into the development organisation as the asset is prepared for launch Act as the bridge between Global and Operations and lead the commercial brand team (CBT) consisting of the top 10 global affiliates
An essential part of this new VP’s success is connected to identifying where and how to focus our launch activities in a highly competitive market with substantial differences across regions. They will need to navigate through the varying needs and conditions of the insulin market, which depend not only on regional differences but also on how we maximise resources available locally.Qualifications
As a candidate for the role, you are an experienced strategic marketer with:Over 10 years of pharmaceutical marketing management experience coupled with people management responsibility Strong strategic, analytical, and financial acumen, to make informed commercial decisions. A proven track record of pre-launch, launch and execution of in-market brands strategies across a variety of market archetypes A proven track record of driving global strategic projects, from scoping to implementation A proven track record of campaign building and global brand management coupled with operational experience from an affiliate and/ or region Commercial knowledge of multi-channel engagement strategies An academic degree in Business Administration, Economics, Marketing, Medicine, or a related disciplines As a driven and purposeful leader, you bring exceptional people leadership capabilities and a passion for leading high-performing teams within a matrix organisation. Your strong business acumen, stakeholder management skills, and impactful communication style enable you to drive complex decision making with internal and external stakeholders alike.Above all, you are a true team player ready for an exciting and once in a life-time senior commercial role within a team of driven commercial professionals engaged in leading innovative commercial strategies and launches across the global organisation.The role is based in Denmark.About the department
The global Icodec & Insulin Portfolio unit within Commercial Strategy and Corporate Affairs (CSCA) is globally responsible for developing and commercialising the insulin portfolio of both in-market products as well as driving the launch strategy and execution of two pipeline assets that are currently in clinical development including IcoSema. The team is responsible for setting the global strategic direction for the portfolio of brands through a co-creation approach with both global, regional and affiliate stakeholders. Driving portfolio strategies and ensuring strong tactical programs and tools are available to operations is also part of the key roles and responsibilities.Contact
If you require further information about the role, please contact Executive Search Partner, Heidi Ashby at [email protected].Deadline
November 26, 2023
We will review the applications on an ongoing basis, so we encourage you to apply as soon as possible.We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Reporting to the Global Head of the Insulin Portfolio Unit, the Global Vice President (VP) will own the entire commercial, brand and go-to-market strategy for IcoSema globally and will lead the marketing team in preparing for the launch. The new VP will lead a cross-functional launch team to secure operational readiness of IcoSema in key affiliates.In collaboration with colleagues in the global project and marketing team, regional and affiliate offices, the new VP will:
An essential part of this new VP’s success is connected to identifying where and how to focus our launch activities in a highly competitive market with substantial differences across regions. They will need to navigate through the varying needs and conditions of the insulin market, which depend not only on regional differences but also on how we maximise resources available locally.Qualifications
As a candidate for the role, you are an experienced strategic marketer with:
The global Icodec & Insulin Portfolio unit within Commercial Strategy and Corporate Affairs (CSCA) is globally responsible for developing and commercialising the insulin portfolio of both in-market products as well as driving the launch strategy and execution of two pipeline assets that are currently in clinical development including IcoSema. The team is responsible for setting the global strategic direction for the portfolio of brands through a co-creation approach with both global, regional and affiliate stakeholders. Driving portfolio strategies and ensuring strong tactical programs and tools are available to operations is also part of the key roles and responsibilities.Contact
If you require further information about the role, please contact Executive Search Partner, Heidi Ashby at [email protected].Deadline
November 26, 2023
We will review the applications on an ongoing basis, so we encourage you to apply as soon as possible.We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Marketingmedarbejder", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 3.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Marketingmedarbejder
- Søborg
Lignende jobs
-
Praktikstilling - marketing
Er du i færd med din Bachelor og står du overfor at skulle i praktik i januar 2025? Motiveres du af at kunne bringe dit kreative og strukturerede mindset i spil i en moderne virksomhed i vækst. Så..Få mere info- Marketingmedarbejder
- København
-
Vil du være helten i børnenes hverdagseventyr? Vi ...
Få mere info- Marketingmedarbejder
- Taastrup
-
Marketing Data Analyst
Opportunity Join Our Team as a Digital Marketing Data Analyst!Maersk is a global leader in integrated logistics and have been industry pioneers for over a century. Through innovation and tran..Få mere info- Marketingmedarbejder
- København K
-
SoMe student til Presse, Marketing & Kommunikation...
Har du styr på hvordan en tekst skal se ud til Instagram, og hvordan den skal skrives til LinkedIn? Er du kreativ, har et godt grafisk øje og ved hvad der får folk til at reagere på et opslag på de..Få mere info- Marketingmedarbejder
- København V
Statistik over udbudte jobs som marketingmedarbejdere i Søborg
Herunder ser du udviklingen i udbudte marketingmedarbejder i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal marketingmedarbejdere.
Se flere statistikker her:
Statistik over udbudte marketingmedarbejdere i Søborg over tid
| Dato | Alle jobs som marketingmedarbejdere |
|---|---|
| 4. november 2024 | 2 |
| 3. november 2024 | 2 |
| 2. november 2024 | 2 |
| 1. november 2024 | 2 |
| 31. oktober 2024 | 2 |
| 30. oktober 2024 | 2 |
| 29. oktober 2024 | 2 |
| 28. oktober 2024 | 3 |
| 27. oktober 2024 | 4 |
| 26. oktober 2024 | 3 |
| 25. oktober 2024 | 3 |
| 24. oktober 2024 | 4 |
| 23. oktober 2024 | 3 |
| 22. oktober 2024 | 4 |
| 21. oktober 2024 | 4 |
| 20. oktober 2024 | 4 |
| 19. oktober 2024 | 4 |
| 18. oktober 2024 | 5 |
| 17. oktober 2024 | 4 |
| 16. oktober 2024 | 4 |
| 15. oktober 2024 | 4 |
| 14. oktober 2024 | 3 |
| 13. oktober 2024 | 3 |
| 12. oktober 2024 | 3 |
| 11. oktober 2024 | 3 |
| 10. oktober 2024 | 2 |
| 9. oktober 2024 | 3 |
| 8. oktober 2024 | 2 |
| 7. oktober 2024 | 2 |
| 6. oktober 2024 | 2 |
| 5. oktober 2024 | 2 |